web analytics
September 28, 2016 / 25 Elul, 5776

Posts Tagged ‘Teva Pharmaceuticals’

BDSers Call for an ‘AidCott’ of Soros for Daring to Invest in Israel

Tuesday, May 27th, 2014

Ask anyone deeply involved in the current social wars against Israel to name the biggest funders of the hate, and one of the first names they’ll offer is George Soros.

But recent reports revealed that Soros invested in the popular carbonated drink maker Soda Stream, one of whose factories is located in Maale Adumim, a suburb of Jerusalem one the haters’ wrong side of the Green Line. It was also revealed that the aging billionaire increased his holdings in Teva Pharmaceuticals, an Israel company which manufactures generic drugs.

Now Soros is in the doghouse along with everyone else who dares to invest their money in Israeli companies.

As reported in The Tower, The Palestinian BDS National Committee posted an official statement on its website, BDSMovement.Net, calling for

a boycott of the Soros Fund Management and the Open Society Foundations due to the recently announced investment by Soros in SodaStream stock and increased investment in Teva Pharmaceuticals, both Israeli companies

which, the BNC  says, violate international law.

The BDS movement teaches that Israeli communities and businesses located beyond the 1949 Armistice Line (often referred to as the Green Line) constitute war crimes.

Teva Pharmaceuticals is despised because, although its offices are located in Petach Tikva, within the 1949 Armistice Line, “Teva enjoys the benefits generated by the Israeli occupation of Palestinian lands, allowing the company to exploit the Palestinian market,” according to a local human rights group.

The Soros universe of beneficiaries apparently includes just about every center-left to further-left to extreme-left group imaginable. A site gives a lengthy list – with links – of organizations to which Soros has funneled billions of dollars including, of course, Media Matters for America, the New America Foundation, the Center for Constitutional Rights, Human Rights Watch, Amnesty International, the American Friends Service Committee, and The Tides Foundation, all of which have been extremely hostile to Israel.

In a fascinating twist, the BNC suggests all the Israel-bashing and trashing organizations which have been feeding at the Soros waterhole for so long engage in a reverse boycott, an “aidcott.”

Usually the goal of economic warfare against problematic practices is to encourage as many people as possible to refrain from patronizing the alleged wrongdoer so that its profits plummet and the wrongdoer stops engaging in the criticized activity in order to turn on again the lifeblood flow of cash.

In this case, the BNC is telling non-profit organizations that they should tell Soros unless he “cleans his investment portfolio,”and stops investing in (profitable) Israeli companies, they should threaten Soros that they will “refrain from applying for funds from those foundations.”

You can no longer say the BDS movement never produced anything original – aidcott is a first.

“Teva enjoys the advantages generated by the Israeli occupation of Palestinian lands allowing the company to exploit the Palestinian market. – See more at: http://www.bdsmovement.net/2014/soros-funds-foundations-investments-israeli-violations-12092?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bdsmovement+%28Palestinian+BDS+National+Committee%29#sthash.Sv1spGYK.XzgCionX.dpuf
a boycott of the Soros Fund Management and the Open Society Foundations due to the recently announced[1]  – first-quarter 2014 — investment by Soros in SodaStream stock and increased investment in Teva Pharmaceuticals, both Israeli companies that are deeply involved in violations of international law. – See more at: http://www.bdsmovement.net/2014/soros-funds-foundations-investments-israeli-violations-12092?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bdsmovement+%28Palestinian+BDS+National+Committee%29#sthash.Sv1spGYK.XzgCionX.dpuf
called today for a boycott of the Soros Fund Management and the Open Society Foundations due to the recently announced[1]  – first-quarter 2014 — investment by Soros in SodaStream stock and increased investment in Teva Pharmaceuticals, both Israeli companies that are deeply involved in violations of international law. – See more at: http://www.bdsmovement.net/2014/soros-funds-foundations-investments-israeli-violations-12092?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bdsmovement+%28Palestinian+BDS+National+Committee%29#sthash.Sv1spGYK.XzgCionX.dpuf

called today for a boycott of the Soros Fund Management and the Open Society Foundations due to the recently announced[1]  – first-quarter 2014 — investment by Soros in SodaStream stock and increased investment in Teva Pharmaceuticals, both Israeli companies that are deeply involved in violations of international law. – See more at: http://www.bdsmovement.net/2014/soros-funds-foundations-investments-israeli-violations-12092?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bdsmovement+%28Palestinian+BDS+National+Committee%29#sthash.Sv1spGYK.XzgCionX.dpuf
called today for a boycott of the Soros Fund Management and the Open Society Foundations due to the recently announced[1]  – first-quarter 2014 — investment by Soros in SodaStream stock and increased investment in Teva Pharmaceuticals, both Israeli companies that are deeply involved in violations of international law. – See more at: http://www.bdsmovement.net/2014/soros-funds-foundations-investments-israeli-violations-12092?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bdsmovement+%28Palestinian+BDS+National+Committee%29#sthash.Sv1spGYK.XzgCionX.dpuf
called today for a boycott of the Soros Fund Management and the Open Society Foundations due to the recently announced[1]  – first-quarter 2014 — investment by Soros in SodaStream stock and increased investment in Teva Pharmaceuticals, both Israeli companies that are deeply involved in violations of international law. – See more at: http://www.bdsmovement.net/2014/soros-funds-foundations-investments-israeli-violations-12092?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bdsmovement+%28Palestinian+BDS+National+Committee%29#sthash.Sv1spGYK.XzgCionX.dpuf
Lori Lowenthal Marcus

Teva Names New CEO Three Months after Firing Jeremy Levin

Thursday, January 9th, 2014

Teva Pharmaceutical announced on Thursday that its new CEO will be Erez Vigodman, who until now has been the CEO for the huge phosphate and chemical producer Makhteshim Agan Industries.

Vigodman replaces Dr. Jeremy Levin, who moved to Israel two years to take over the world’s largest generic drug company, which has been faltering since a rival firm began marketing a generic alternative to Teva’s conventional Copaxone drug that prevents the reoccurrence of Muscular Sclerosis.

Levin was fired after arguments on company strategy between him and the board of directors.

Teva chairman Dr. Phillip Frost said, “As a member of the Teva board since 2009, Erez has a deep understanding of the company and the industry in which it operates, putting him in a strong position to hit the ground running and deliver value for shareholders.”

Jewish Press News Briefs

Teva to Fire 5,000 Workers Worldwide

Thursday, October 10th, 2013

Israel’s giant generic Teva Pharmaceuticals firm will fire  by the end of next year 5,000 employees around the world, including hundreds in Israel, as one of the “steps to accelerate the reduction of costs and to optimize its structure.”

Most of the layoffs will be outside Israel, said Teva CEO Jeremy Levin, who moved to Israel form the United States last year to head the company.

The layoffs are expected to save the company $1.5 to $2 billion by the end of 2017, and part of the savings will be re-invested in the development of generic and specialty drugs.

Levin maintained  that the company is not suffering from financial problems. In New York, the company’s shares jumped 2 percent on news of the cutback in the workforce.

Teva’s stock was the darling of investors until five years ago, when the announcement of competitors’  generic drugs to replace Teva’s patented Copaxone drug, which treats  multiple sclerosis, drove the stock down by nearly 50 percent.

Jewish Press News Briefs

Teva Opens Massive Plant in Hungary

Monday, October 15th, 2012

Teva Pharmaceuticals has opened a new $110 million plant in Hungary, set to be one of the largest sterile medicines plants in the world.

The 15,000 square meter plant will work primarily in oncology therapeutics, and will produce 160-200 million units of injectables a year.

Teva has been operating in Hungary since 1993, operating a tablet production facility, an advanced pharmaceutical ingredients manufacturing plant, and now the sterile plant, and employs 3,5000 Hungarians.

Malkah Fleisher

Printed from: http://www.jewishpress.com/news/teva-opens-massive-plant-in-hungary/2012/10/15/

Scan this QR code to visit this page online: